Search Results 1121-1130 of 38048 for Two-phase

1. Publications - Gerardo Colon-Otero, M.D. - Mayo Clinic

   Phase 2 trial of everolimus and letrozole in relapsed estrogen receptor-positive high-grade ovarian cancers. Gynecol Oncol. 2017 Jul; 146(1):64-68. Epub ...

2. Access to telerehabilitation services can improve outcomes in patients with late-stage cancer - Mayo Clinic

   In study findings published in JAMA Oncology, Mayo Clinic researchers studied patients with late-stage cancer who participated in a collaborative ...

3. Diabetes - Symptoms and causes - Mayo Clinic

   And prediabetes can lead to diabetes unless steps are taken to prevent it. ... Glucose comes from two major sources: food and the liver. ... In fact, prediabetes ...

4. Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

5. Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma (SEQUEL) - Mayo Clinic

   This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...

6. Heart Attack Clinical Trials - Mayo Clinic Research

   A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction Scottsdale/Phoenix, AZ. This is a double-blind, sham ...

7. Patients with skin disease show response to targeted treatment - Mayo Clinic News Network

   They described their findings in a study recently published in the Journal of Clinical Investigation that described their first-in-human, phase 2 clinical trial ...

8. NRG-GY012 “A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combinations of Cediranib/Olaparib, Olaparib/Durvalumab (MEDI4736), Cediranib/Durvalumab (MEDI4736), Olaparib/AZD5356 (Capivasertib) in Women with Recurrent, Persistent or Metastatic Endometrial Cancer. A Multi-Arm Trial for Women with Recurrent or Persistent Endometrial Cancer” - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

9. Vitiligo - Symptoms & causes - Mayo Clinic

   This type, called segmental vitiligo, tends to occur at a younger age, progress for a year or two, then stop. One or only a few areas of the body. This type ...

10. Cirrhosis - Diagnosis and treatment - Mayo Clinic

    ... two years without liver transplant. Many things can influence life expectancy for each person, including complications and treatment. At this stage, care ...